{
  "name": "TEST-TPQ",
  "description": "The target promotion questionnaire is used to promote a gene to target",
  "version": null,
  "questions": [
    {
      "identification": "2A1",
      "module": "TargetPromotionQuestions",
      "section": "Section 2: Impact of Chemical Inhibition",
      "subSection": "(a) during infections",
      "questionBody": " In Humans, is there evidence that an inhibitor of this target contributes to durable cure of tuberculosis?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "423ee452-bc62-4aad-a97b-546bc91e4afe",
          "answer": "NO",
          "description": "A clinical trial suggest that inhibition of this target does not improve TB chemotherapy in humans.",
          "isInverted": null,
          "weight": 0,
          "id": "1be7862e-e4b0-4cea-ac69-e31edbd942a7",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "423ee452-bc62-4aad-a97b-546bc91e4afe",
          "answer": "YES",
          "description": "An approved drug that engages this target and has shown to be part of a sterilizing regimen.",
          "isInverted": null,
          "weight": 49.5,
          "id": "fb941679-d919-495e-a3c8-5b4b48567103",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "423ee452-bc62-4aad-a97b-546bc91e4afe",
          "answer": "UNKNOWN",
          "description": "No drug or candidate that engages the target has progressed to a level of clinical evaluation that could demonstrate a contribution to a durable cure.  Alternatively, a clinical trial was inconclusive.",
          "isInverted": null,
          "weight": 0.5,
          "id": "3370b2b4-5a8c-401d-a99f-fe651812fed2",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "423ee452-bc62-4aad-a97b-546bc91e4afe",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "2A1B",
      "module": "TargetPromotionQuestions",
      "section": "Section 2: Impact of Chemical Inhibition",
      "subSection": "(a) during infections",
      "questionBody": "In Humans, has an inhibitor of this target shown efficacy in a phase IIb or Early Bactericidal Activity trial?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "aa1bfac1-ad46-4c18-828a-c7b9bc504a91",
          "answer": "UNKNOWN",
          "description": "No drug that engages the target has progressed to a Phase 2 EBA study.  Alternatively, the level of target engagement for a particular drug that has progressed to an EBA study is uncertain.",
          "isInverted": null,
          "weight": 0,
          "id": "4a6fbf12-ed3c-4450-9d32-1c04d0a46e7e",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "aa1bfac1-ad46-4c18-828a-c7b9bc504a91",
          "answer": "YES",
          "description": "A drug that engages the target was shown to be active in an EBA study as determined by the clinical team.",
          "isInverted": null,
          "weight": 0,
          "id": "eb7d1448-c5e5-4eb7-95cd-559afe135d23",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "aa1bfac1-ad46-4c18-828a-c7b9bc504a91",
          "answer": "NO",
          "description": "A drug that engages the target was shown to be inactive in an EBA study as determined by the clinical team.",
          "isInverted": null,
          "weight": 0,
          "id": "ab0f63c5-18da-45dc-ac76-c1fab3660e5f",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "aa1bfac1-ad46-4c18-828a-c7b9bc504a91",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "2A2",
      "module": "TargetPromotionQuestions",
      "section": "Section 2: Impact of Chemical Inhibition",
      "subSection": "(a) during infections",
      "questionBody": "In non-human primates has an inhibitor of this target shown efficacy?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "86fd511d-e122-42f7-9e99-b3fc6866fa07",
          "answer": "ACTIVE",
          "description": "A compound that engages the target was shown to be active in a NHP study as determined by the study team.",
          "isInverted": null,
          "weight": 14.85,
          "id": "910e3f90-f97c-416b-968f-5f7522a8c4c4",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "86fd511d-e122-42f7-9e99-b3fc6866fa07",
          "answer": "INACTIVE",
          "description": "A compound that engages the target was shown to be inactive in a NHP study as determined by the study team.",
          "isInverted": null,
          "weight": 0,
          "id": "1306ab66-0a58-471d-b5f0-ce8c66050fe9",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "86fd511d-e122-42f7-9e99-b3fc6866fa07",
          "answer": "UNKNOWN",
          "description": "No compound that engages the target has progressed to a non-human primate efficacy study.  Alternatively, the level of target engagement for a particular compound that has progressed to a NHP study is uncertain.",
          "isInverted": null,
          "weight": 0.15,
          "id": "e2e4edd6-b1e4-47ec-ad4e-45024a4c98bb",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "86fd511d-e122-42f7-9e99-b3fc6866fa07",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "2A4A",
      "module": "TargetPromotionQuestions",
      "section": "Section 2: Impact of Chemical Inhibition",
      "subSection": "(a) during infections",
      "questionBody": "In either a C57BL/6 or BALB/c tuberculosis acute mouse model has an inhibitor of this target shown efficacy?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "0402e931-370a-4ca4-bfb7-f53c0868801a",
          "answer": "UNKNOWN",
          "description": "No compound that engages the target has progressed to a C57BL/6 or BALB/c-Acute infection efficacy study.  Alternatively, the level of target engagement for a particular compound that has progressed to a C57BL/6 or BALB/c-Acute infection efficacy study is uncertain.",
          "isInverted": null,
          "weight": 0.11,
          "id": "185eb3d4-a248-49f9-b8b0-9e594aa6184c",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "0402e931-370a-4ca4-bfb7-f53c0868801a",
          "answer": "ACTIVE",
          "description": "A compound that engages the target was shown to be active in a C57BL/6 or BALB/c-Acute infection efficacy study.",
          "isInverted": null,
          "weight": 10.89,
          "id": "db70a496-ce06-4f9e-9101-af42643ddce7",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "0402e931-370a-4ca4-bfb7-f53c0868801a",
          "answer": "INACTIVE",
          "description": "A compound that engages the target was shown to be inactive in a C57BL/6 or BALB/c-Acute infection efficacy study.",
          "isInverted": null,
          "weight": 0,
          "id": "1a81d93c-9e3d-42dc-80c4-26551505c592",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "0402e931-370a-4ca4-bfb7-f53c0868801a",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "2A4B",
      "module": "TargetPromotionQuestions",
      "section": "Section 2: Impact of Chemical Inhibition",
      "subSection": "(a) during infections",
      "questionBody": "In either a C57BL/6 or BALB/c tuberculosis chronic mouse model has an inhibitor of this target shown efficacy?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "1948372c-7472-46ed-a8bb-4142ac5f3ca0",
          "answer": "INACTIVE",
          "description": "A compound that engages the target was shown to be inactive in a C57BL/6 or BALB/c-Chronic infection efficacy study.",
          "isInverted": null,
          "weight": 0,
          "id": "ba93424e-9173-42d0-b755-6ec14e3d2b40",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "1948372c-7472-46ed-a8bb-4142ac5f3ca0",
          "answer": "ACTIVE",
          "description": "A compound that engages the target was shown to be active in a C57BL/6 or BALB/c-Chronic infection efficacy study.",
          "isInverted": null,
          "weight": 10.89,
          "id": "9975cd3a-4a48-429f-b6bb-ba43bdba48d4",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "1948372c-7472-46ed-a8bb-4142ac5f3ca0",
          "answer": "UNKNOWN",
          "description": "No compound that engages the target has progressed to a C57BL/6 or BALB/c-Chronic infection efficacy study.  Alternatively, the level of target engagement for a particular compound that has progressed to a C57BL/6 or BALB/c-Chronic infection efficacy study is uncertain.",
          "isInverted": null,
          "weight": 0.11,
          "id": "2853e86b-94cf-418c-b39f-fa40e200532a",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "1948372c-7472-46ed-a8bb-4142ac5f3ca0",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "2A5",
      "module": "TargetPromotionQuestions",
      "section": "Section 2: Impact of Chemical Inhibition",
      "subSection": "(a) during infections",
      "questionBody": "Has an inhibitor of this target shown activity in a mTB macrophage assay?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "f397ac6f-1545-4986-b23e-d9bb968482e0",
          "answer": "UNKNOWN",
          "description": "No compound that engages the target has been tested in a macrophage assay.  Alternatively, the level of target engagement for a particular compound that has been tested in a macrophage assay is uncertain.",
          "isInverted": null,
          "weight": 0.02,
          "id": "fc6c7f55-b532-412d-ad3c-660804f2d912",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "f397ac6f-1545-4986-b23e-d9bb968482e0",
          "answer": "INACTIVE",
          "description": "A compound that engages the target was shown to be inactive in a macrophage assay.",
          "isInverted": null,
          "weight": 0,
          "id": "e3735f46-1411-4c5e-aaf1-56dea2399a26",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "f397ac6f-1545-4986-b23e-d9bb968482e0",
          "answer": "ACTIVE",
          "description": "A compound that engages the target was shown to be active in a macrophage assay.",
          "isInverted": null,
          "weight": 1.98,
          "id": "f437a533-d6d0-46da-bf02-7b6f4f60fc94",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "f397ac6f-1545-4986-b23e-d9bb968482e0",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "2B1",
      "module": "TargetPromotionQuestions",
      "section": "Section 2: Impact of Chemical Inhibition",
      "subSection": "(b) on replicating Mtb in vitro",
      "questionBody": "Has an inhibitor of this target shown activity against mTB in Standard media?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "75430f66-c81a-4d5e-89da-ce32b9acee7b",
          "answer": "ACTIVE",
          "description": "A compound that engages the target was shown to be active in an Mtb assay using standard media.",
          "isInverted": null,
          "weight": 49.5,
          "id": "90630c16-7d59-4748-be50-62933f9834ab",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "75430f66-c81a-4d5e-89da-ce32b9acee7b",
          "answer": "INACTIVE",
          "description": "A compound that engages the target was shown to be inactive in an Mtb assay using standard media.",
          "isInverted": null,
          "weight": 0,
          "id": "0c4f1efd-26e1-4ee9-b676-8fa27bf3b56c",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "75430f66-c81a-4d5e-89da-ce32b9acee7b",
          "answer": "UNKNOWN",
          "description": "No compound that engages the target has been tested in an Mtb assay using standard media.  Alternatively, the level of target engagement for a particular compound that has been tested in an Mtb assay using standard media is uncertain.",
          "isInverted": null,
          "weight": 0.5,
          "id": "555796e3-cb6d-49b5-bfc5-4148bad1d168",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "75430f66-c81a-4d5e-89da-ce32b9acee7b",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "2B2",
      "module": "TargetPromotionQuestions",
      "section": "Section 2: Impact of Chemical Inhibition",
      "subSection": "(b) on replicating Mtb in vitro",
      "questionBody": "Has an inhibitor of this target shown activity against mTB in media with a gluconeogenic carbon source?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "15359627-6fb8-440d-b29e-197637294eae",
          "answer": "ACTIVE",
          "description": "A compound that engages the target was shown to be active in an Mtb assay using a gluconeogenic carbon source.  Please describe conditions.",
          "isInverted": null,
          "weight": 24.75,
          "id": "d04a4017-b772-4b43-bb26-6dc3cf2d7723",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "15359627-6fb8-440d-b29e-197637294eae",
          "answer": "UNKNOWN",
          "description": "No compound that engages the target has been tested in an Mtb assay using a gluconeogenic carbon source.  Alternatively, the level of target engagement for a particular compound that has been tested in an Mtb assay using a gluconeogenic carbon source is uncertain. Please describe conditions.",
          "isInverted": null,
          "weight": 0.25,
          "id": "d6dd9139-e941-4374-9f39-08581834a624",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "15359627-6fb8-440d-b29e-197637294eae",
          "answer": "INACTIVE",
          "description": "A compound that engages the target was shown to be inactive in an Mtb assay using a gluconeogenic carbon source. Please describe conditions.",
          "isInverted": null,
          "weight": 0,
          "id": "201e6768-7e15-4ee0-a72b-8fe2e9869a64",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "15359627-6fb8-440d-b29e-197637294eae",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "2B4",
      "module": "TargetPromotionQuestions",
      "section": "Section 2: Impact of Chemical Inhibition",
      "subSection": "(b) on replicating Mtb in vitro",
      "questionBody": "Has an inhibitor of this target shown activity against mTB in media under other conditions (neither standard nor gluconeogenic carbon sources)?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "ea2e3433-3625-4b53-a520-aee92ccfcc0c",
          "answer": "INACTIVE",
          "description": "A compound that engages the target was shown to be inactive in an Mtb assay under other conditions. Please describe conditions.",
          "isInverted": null,
          "weight": 0,
          "id": "4a1856bf-3532-4802-a311-0c4890910d92",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "ea2e3433-3625-4b53-a520-aee92ccfcc0c",
          "answer": "ACTIVE",
          "description": "A compound that engages the target was shown to be active in an Mtb assay under other conditions.  Please describe conditions.",
          "isInverted": null,
          "weight": 24.75,
          "id": "d5c9a1cd-c15a-4a1f-8ef0-8b736dacf442",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "ea2e3433-3625-4b53-a520-aee92ccfcc0c",
          "answer": "UNKNOWN",
          "description": "No compound that engages the target has been tested in an Mtb assay under other conditions.  Alternatively, the level of target engagement for a particular compound that has been tested in an Mtb assay under other conditions is uncertain.  Please describe conditions.",
          "isInverted": null,
          "weight": 0.25,
          "id": "2ae72e7f-6826-4bcd-a99c-286b5adbb7a0",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "ea2e3433-3625-4b53-a520-aee92ccfcc0c",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "2C3",
      "module": "TargetPromotionQuestions",
      "section": "Section 2: Impact of Chemical Inhibition",
      "subSection": "(c) on nonreplicating Mtb in vitro",
      "questionBody": "Has an inhibitor of this target shown activity against mTB in Caseum or a caseum surrogate? ",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "49488323-7b56-4562-aa09-7fc1e607d815",
          "answer": "UNKNOWN",
          "description": "No compound that engages the target has been tested in an Mtb assay in caseum or caseum surrogate.  Alternatively, the level of target engagement for a particular compound that has been tested in an Mtb assay in caseum is uncertain.  Please describe conditions.",
          "isInverted": null,
          "weight": 0.9,
          "id": "64339af1-c124-4a1b-9a05-68b7ccdc4fbf",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "49488323-7b56-4562-aa09-7fc1e607d815",
          "answer": "ACTIVE",
          "description": "A compound that engages the target was shown to be active in an Mtb assay in caseum or caseum surrogate. Please describe conditions.",
          "isInverted": null,
          "weight": 89.1,
          "id": "9a677515-1393-4c3f-b256-f6fa1c3c35b8",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "49488323-7b56-4562-aa09-7fc1e607d815",
          "answer": "INACTIVE",
          "description": "A compound that engages the target was shown to be inactive in an Mtb assay in caseum or caseum surrogate. Please describe conditions.",
          "isInverted": null,
          "weight": 0,
          "id": "3cefb3fe-1136-4ca9-b4ef-c09b8ad30027",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "49488323-7b56-4562-aa09-7fc1e607d815",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "2C5",
      "module": "TargetPromotionQuestions",
      "section": "Section 2: Impact of Chemical Inhibition",
      "subSection": "(c) on nonreplicating Mtb in vitro",
      "questionBody": "Has an inhibitor of this target shown activity against mTB in a non-replicating assay (other than caseum or a caseum surrogate)?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "0171f15f-5ae9-4689-a7b8-5316dae3a668",
          "answer": "UNKNOWN",
          "description": "No compound that engages the target has been tested in an Mtb assay under other NR conditions.  Alternatively, the level of target engagement for a particular compound that has been tested in an Mtb assay under other NR conditions is uncertain.  Please describe conditions.",
          "isInverted": null,
          "weight": 0.1,
          "id": "d65c28dc-7711-4058-83b4-fb9180e5e149",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "0171f15f-5ae9-4689-a7b8-5316dae3a668",
          "answer": "ACTIVE",
          "description": "A compound that engages the target was shown to be active in an Mtb assay under other NR conditions.  Please describe conditions.",
          "isInverted": null,
          "weight": 9.9,
          "id": "274c7bb9-00e9-4977-ba07-115487d945ab",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "0171f15f-5ae9-4689-a7b8-5316dae3a668",
          "answer": "INACTIVE",
          "description": "A compound that engages the target was shown to be inactive in an Mtb assay under other NR conditions. Please describe conditions.",
          "isInverted": null,
          "weight": 0,
          "id": "092842fa-1420-4182-8b76-435dee5877d8",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "0171f15f-5ae9-4689-a7b8-5316dae3a668",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "3A1",
      "module": "TargetPromotionQuestions",
      "section": "Section 3: Chemical Inhibition",
      "subSection": "(a) on-target whole-cell activity (live Mtb)",
      "questionBody": "Have mutation studies been performed on inhibitors of this target show that mutations in the target causes resistance?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "9922d62f-2882-4a7e-aad0-3699c6fe35f5",
          "answer": "YES",
          "description": "Compounds show differential activity between wild type and bacteria with mutations in the target.",
          "isInverted": null,
          "weight": 16.5,
          "id": "ed38fc6a-94fc-4351-9431-61ef6a72d9a2",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "9922d62f-2882-4a7e-aad0-3699c6fe35f5",
          "answer": "NO",
          "description": "Compounds do not show differential activity between wild type and bacteria with mutations in the target.",
          "isInverted": null,
          "weight": 0,
          "id": "04917cf2-a57c-4346-97b7-52d3760a61a0",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "9922d62f-2882-4a7e-aad0-3699c6fe35f5",
          "answer": "UNKNOWN",
          "description": "Mutation studies have not been undertaken on compounds that are thought to engage the target.  Alternatively, mutation studies on compounds that are thought to engage the target are inconclusive.",
          "isInverted": null,
          "weight": 0.2,
          "id": "4ad7aefd-8a8a-469e-a295-eb90bcac315e",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "9922d62f-2882-4a7e-aad0-3699c6fe35f5",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "3A2",
      "module": "TargetPromotionQuestions",
      "section": "Section 3: Chemical Inhibition",
      "subSection": "(a) on-target whole-cell activity (live Mtb)",
      "questionBody": "Does overexpression of this target increases MIC values?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "0014c1e6-0741-470a-8043-810ae0e9928c",
          "answer": "UNKNOWN",
          "description": "Testing compounds on bacteria that over express the target has not been undertaken.  Alternatively, overexpression studies on compounds that are thought to engage the target are inconclusive.",
          "isInverted": null,
          "weight": 0.2,
          "id": "104432d2-d9e2-43af-9f6e-d712f76d4892",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "0014c1e6-0741-470a-8043-810ae0e9928c",
          "answer": "YES",
          "description": "Compounds show differential activity between wild type and bacteria that overexpress the target.",
          "isInverted": null,
          "weight": 16.5,
          "id": "60383858-ad0b-4dce-9b82-704c97b55dba",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "0014c1e6-0741-470a-8043-810ae0e9928c",
          "answer": "NO",
          "description": "Compounds do not show differential activity between wild type and bacteria that overexpress the target.",
          "isInverted": null,
          "weight": 0,
          "id": "17a4e1ac-5e68-4282-8311-a6c957c80d6e",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "0014c1e6-0741-470a-8043-810ae0e9928c",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "3A3",
      "module": "TargetPromotionQuestions",
      "section": "Section 3: Chemical Inhibition",
      "subSection": "(a) on-target whole-cell activity (live Mtb)",
      "questionBody": "Does underexpression of target decreases MIC?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "51b0e63b-7dda-4dd2-becd-ef1d0b60e1e4",
          "answer": "UNKNOWN",
          "description": "Testing compounds on bacteria that under express the target has not been undertaken.  Alternatively, underexpression studies on compounds that are thought to engage the target are inconclusive.",
          "isInverted": null,
          "weight": 0.2,
          "id": "c55a740e-3889-4f04-9d1c-23fd479bd4ff",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "51b0e63b-7dda-4dd2-becd-ef1d0b60e1e4",
          "answer": "NO",
          "description": "Compounds do not show differential activity between wild type and bacteria that underexpress the target.",
          "isInverted": null,
          "weight": 0,
          "id": "ba10577a-00a9-40a7-8f5c-8bf35ab84c40",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "51b0e63b-7dda-4dd2-becd-ef1d0b60e1e4",
          "answer": "YES",
          "description": "Compounds show differential activity between wild type and bacteria that underexpress the target.",
          "isInverted": null,
          "weight": 16.5,
          "id": "df414f57-fd33-4688-9ab9-315b191c42e7",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "51b0e63b-7dda-4dd2-becd-ef1d0b60e1e4",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "3A4",
      "module": "TargetPromotionQuestions",
      "section": "Section 3: Chemical Inhibition",
      "subSection": "(a) on-target whole-cell activity (live Mtb)",
      "questionBody": "Do inhibitors of this target show an impact of the biochemical pathway this target is part of?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "d2eae599-1b33-429a-92e7-506cd38a1f1a",
          "answer": "YES",
          "description": "Compounds have an impact on the pathway that the target of interest is part of. Please describe studies that were undertaken.",
          "isInverted": null,
          "weight": 16.5,
          "id": "defc7477-4085-4c24-9d81-de7fa637e1d8",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "d2eae599-1b33-429a-92e7-506cd38a1f1a",
          "answer": "UNKNOWN",
          "description": "Pathway studies have not been undertaken on compounds that are thought to engage the target.  Alternatively, pathway studies on compounds that are thought to engage the target are inconclusive.  Please describe studies that were undertaken.",
          "isInverted": null,
          "weight": 0.2,
          "id": "d72e8a99-c36d-4ed2-bf1c-a2c596e823d8",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "d2eae599-1b33-429a-92e7-506cd38a1f1a",
          "answer": "NO",
          "description": "Compounds do not have an impact on the pathway that the target of interest is part of. Please describe studies that were undertaken.",
          "isInverted": null,
          "weight": 0,
          "id": "78693ade-9480-4dd5-b69b-d67ace54efa7",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "d2eae599-1b33-429a-92e7-506cd38a1f1a",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "3B1",
      "module": "TargetPromotionQuestions",
      "section": "Section 3: Chemical Inhibition",
      "subSection": "(b) Biochemical activity (isolated target)",
      "questionBody": "Is there evidence that compounds that inhibit this target bind purified protein?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "f3e66764-087f-471b-ad56-61c8ba28a386",
          "answer": "NO",
          "description": "Compounds do not bind purified target.  Please describe type of study.",
          "isInverted": null,
          "weight": 0,
          "id": "2ebbd133-49f3-4ca1-b097-6ccd198e61d7",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "f3e66764-087f-471b-ad56-61c8ba28a386",
          "answer": "UNKNOWN",
          "description": "Binding studies have not been undertaken on compounds that are thought to engage the target.  Alternatively, binding studies on compounds that are thought to engage the target are inconclusive.  Please describe type of study.",
          "isInverted": null,
          "weight": 0.2,
          "id": "0cd490b6-99b9-47b2-a558-0d80dacddeae",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "f3e66764-087f-471b-ad56-61c8ba28a386",
          "answer": "YES",
          "description": "Compounds bind purified target. Please describe type of study.",
          "isInverted": null,
          "weight": 16.5,
          "id": "7ef14939-90a9-42cf-98bb-f40c7b78d41e",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "f3e66764-087f-471b-ad56-61c8ba28a386",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "3B2",
      "module": "TargetPromotionQuestions",
      "section": "Section 3: Chemical Inhibition",
      "subSection": "(b) Biochemical activity (isolated target)",
      "questionBody": "Are there compounds that inhibit purified protein?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "925b0c93-cb75-4770-a0d7-3ef06985934d",
          "answer": "YES",
          "description": "Compounds inhibit purified target. Please describe assay.",
          "isInverted": null,
          "weight": 16.5,
          "id": "1a999236-19b5-4757-a0a5-79b4ae09912b",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "925b0c93-cb75-4770-a0d7-3ef06985934d",
          "answer": "NO",
          "description": "Compounds do not inhibit purified target. Please describe assay.",
          "isInverted": null,
          "weight": 0,
          "id": "d635b67d-4e0f-4c77-8c1f-7fc5817d83b6",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "925b0c93-cb75-4770-a0d7-3ef06985934d",
          "answer": "UNKNOWN",
          "description": "Inhibition studies have not been undertaken on compounds that are thought to engage the target.  Alternatively, inhibition studies on compounds that are thought to engage the target are inconclusive. Please describe assay.",
          "isInverted": null,
          "weight": 0.2,
          "id": "958b7b76-1e99-453e-99df-fad707a4d960",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "925b0c93-cb75-4770-a0d7-3ef06985934d",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "4A3A",
      "module": "TargetPromotionQuestions",
      "section": "Section 4: Impact of Genetic Inhibition",
      "subSection": "(a) during infections",
      "questionBody": "Have hypomorph or hypermorphs of this target show a different infection course in a C57BL/6 or BALB/c-Acute mouse model?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "48abcbe6-14bf-4580-ab50-40e9dd68f542",
          "answer": "UNKNOWN",
          "description": "Genetically modified bacteria have not been tested in a C57BL/6 or BALB/c-Acute efficacy study.  Alternatively, the outcome from genetically modified bacteria in an acute C57BL/6 or BALB/c mouse study was inconclusive.",
          "isInverted": null,
          "weight": 0.5,
          "id": "0960be4f-f219-4abb-9fed-9c581a1636a4",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "48abcbe6-14bf-4580-ab50-40e9dd68f542",
          "answer": "ACTIVE",
          "description": "There was a significant impact on the course of the infection in a C57BL/6 or BALB/c-Acute study with genetically modified bacteria.",
          "isInverted": null,
          "weight": 49.5,
          "id": "d3a1b586-3ac4-4b71-a36b-6576af6df90d",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "48abcbe6-14bf-4580-ab50-40e9dd68f542",
          "answer": "INACTIVE",
          "description": "There was no significant impact on the course of the infection in a C57BL/6 or BALB/c-Acute study with genetically modified bacteria.",
          "isInverted": null,
          "weight": 0,
          "id": "4be8c3b0-2e90-4d46-80fb-b5574b766b7b",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "48abcbe6-14bf-4580-ab50-40e9dd68f542",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "4A3B",
      "module": "TargetPromotionQuestions",
      "section": "Section 4: Impact of Genetic Inhibition",
      "subSection": "(a) during infections",
      "questionBody": "Have hypomorph or hypermorphs of this target show a different infection course in a C57BL/6 or BALB/c-chronic mouse model?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "42eb9699-e066-474d-bc64-9fed34f453a3",
          "answer": "ACTIVE",
          "description": "There was a significant impact on the course of the infection in a C57BL/6 or BALB/c-Chronic study with genetically modified bacteria.",
          "isInverted": null,
          "weight": 49.5,
          "id": "ea6df497-78ad-4da6-8096-7e07fbca2232",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "42eb9699-e066-474d-bc64-9fed34f453a3",
          "answer": "INACTIVE",
          "description": "There was no significant impact on the course of the infection in a C57BL/6 or BALB/c-Chronic study with genetically modified bacteria.",
          "isInverted": null,
          "weight": 0,
          "id": "f0c4fe68-56ae-4dc3-9399-4260ec68f72f",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "42eb9699-e066-474d-bc64-9fed34f453a3",
          "answer": "UNKNOWN",
          "description": "Genetically modified bacteria have not been tested in a C57BL/6 or BALB/c-Chronic efficacy study.  Alternatively, the outcome from genetically modified bacteria in a chronic C57BL/6 or BALB/c mouse study was inconclusive.",
          "isInverted": null,
          "weight": 0.5,
          "id": "aee385f0-47e5-4d81-8425-aff02884e09c",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "42eb9699-e066-474d-bc64-9fed34f453a3",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "4A4",
      "module": "TargetPromotionQuestions",
      "section": "Section 4: Impact of Genetic Inhibition",
      "subSection": "(a) during infections",
      "questionBody": "Have hypomorph or hypermorphs of this target show a different infection course in a macrophage study?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "af7db7b4-0dfc-409e-8492-e229dc624bd5",
          "answer": "UNKNOWN",
          "description": "Genetically modified bacteria have not been tested in a macrophage study.  Alternatively, the outcome from a macrophage study using genetically modified bacteria was inconclusive.",
          "isInverted": null,
          "weight": 0,
          "id": "3701124f-7ca0-4a8e-9275-531016cbe3f0",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "af7db7b4-0dfc-409e-8492-e229dc624bd5",
          "answer": "ACTIVE",
          "description": "Genetic inactivation of the target significantly reduced growth of Mtb (p-value < 0.05) in naÃ¯ve macrophages and/or increased killing by activated macrophages (p-value < 0.05).",
          "isInverted": null,
          "weight": 0,
          "id": "9b0d0572-a176-4b11-8460-6134e7d24e43",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "af7db7b4-0dfc-409e-8492-e229dc624bd5",
          "answer": "INACTIVE",
          "description": "Genetic inactivation of the target did not significantly change growth in or killing by macrophages.",
          "isInverted": null,
          "weight": 0,
          "id": "92fc940f-49e5-4b4e-90ea-b92032c3acd0",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "af7db7b4-0dfc-409e-8492-e229dc624bd5",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "4C3",
      "module": "TargetPromotionQuestions",
      "section": "Section 4: Impact of Genetic Inhibition",
      "subSection": "(c) on nonreplicating Mtb in vitro",
      "questionBody": "Do hypermorphs or hypomorphs of target this target have significantly different growth behavior in caseum or caseum surrogate?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "e493dd1c-cc96-47e4-8e75-983e224ac72f",
          "answer": "INACTIVE",
          "description": "There was not a significant impact on the relative growth behavior of genetically modified bacteria tested in caseum surrogate.  Please describe assay.",
          "isInverted": null,
          "weight": 0,
          "id": "bc2ed45c-12fd-4305-9061-e977b578db57",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "e493dd1c-cc96-47e4-8e75-983e224ac72f",
          "answer": "UNKNOWN",
          "description": "Genetically modified bacteria have not been prepared and/or were not tested in caseum surrogate.  Alternatively, the outcome from a genetically modified bacteria growth study in caseum surrogate was inconclusive.  Please describe assay.",
          "isInverted": null,
          "weight": 0.9,
          "id": "3fe00e55-ef75-4b26-8492-f2e8664f85ad",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "e493dd1c-cc96-47e4-8e75-983e224ac72f",
          "answer": "ACTIVE",
          "description": "There was a significant impact on the relative growth behavior of genetically modified bacteria tested in caseum surrogate.  Please describe assay.",
          "isInverted": null,
          "weight": 89.1,
          "id": "5b5c73bd-7a65-4d39-a68c-cc785252c8f1",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "e493dd1c-cc96-47e4-8e75-983e224ac72f",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "5A1",
      "module": "TargetPromotionQuestions",
      "section": "Section 5: Liabilities",
      "subSection": "a) Metabolic liabilities",
      "questionBody": "Will inhibition/activation of this target be neutralized by a supplement (eg a metabolite) or in specific media?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "cc8de94f-d4c8-4b56-a91f-d04926c6a15a",
          "answer": "YES",
          "description": "The possibility of neutralization of inhibition or inactivation by a supplement or specific media exists and has been demonstrated in vitro or in vivo. Please describe situation.",
          "isInverted": null,
          "weight": 1,
          "id": "3106b75d-13c4-4695-a84d-b08de86a11ee",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "cc8de94f-d4c8-4b56-a91f-d04926c6a15a",
          "answer": "N/A",
          "description": "The possibility of neutralization of inhibition or inactivation by a supplement or specific media does not exist.",
          "isInverted": null,
          "weight": 1,
          "id": "8b84b337-9839-4e29-9126-0f2ff7148c53",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "cc8de94f-d4c8-4b56-a91f-d04926c6a15a",
          "answer": "UNKNOWN",
          "description": "The possibility of inhibition or inactivation neutralization of inhibition or inactivation by a supplement or specific media exists but has not been demonstrated in vitro or in vivo. Please describe situation.",
          "isInverted": null,
          "weight": 1,
          "id": "ad64cd1e-9b04-4b71-8c3c-6ebc227e754d",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "cc8de94f-d4c8-4b56-a91f-d04926c6a15a",
          "answer": "NO",
          "description": "The possibility of neutralization of inhibition or inactivation by a supplement or specific media is theoretically possible but has been excluded experimentally.",
          "isInverted": null,
          "weight": 1,
          "id": "213c353e-f7df-40f8-b8e6-f3b84daa9dce",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "cc8de94f-d4c8-4b56-a91f-d04926c6a15a",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "5A2",
      "module": "TargetPromotionQuestions",
      "section": "Section 5: Liabilities",
      "subSection": "a) Metabolic liabilities",
      "sectionDescription": "",
      "questionBody": "Is the concentration of supplement in human tissue too low to neutralize inactivation of this target? ",

      "toolTip": "",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "4e918e13-3418-4b85-923e-0ab347df3fef",
          "answer": "YES",
          "description": "If it is known that the concentration of supplement in human tissue is too low to neutralize inactivation of the target, please elaborate.",
          "isInverted": null,
          "weight": 1,
          "id": "285abefa-1ad9-4943-8317-0840f7f09d69",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "4e918e13-3418-4b85-923e-0ab347df3fef",
          "answer": "NO",
          "description": "The possibility of neutralization of inhibition or inactivation by a supplement or specific media does not exist.  Alternatively, the possibility of inhibition or inactivation neutralization by a supplement or specific media exists but concentrations in human tissue are insufficient to accomplish this. Please describe situation.",
          "isInverted": null,
          "weight": 0,
          "id": "112bfdf6-2126-4981-a1b7-50e7e395140a",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "4e918e13-3418-4b85-923e-0ab347df3fef",
          "answer": "UNKNOWN",
          "description": "The possibility of neutralization of inhibition or inactivation by a supplement or specific media exists but it is unknown, or it has not been demonstrated that concentrations in human tissue are sufficient to accomplish this. Please describe situation.",
          "isInverted": null,
          "weight": 0.75,
          "id": "088b898f-0a73-4be6-981c-88d1f3bd0ba5",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "4e918e13-3418-4b85-923e-0ab347df3fef",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "5A3",
      "module": "TargetPromotionQuestions",
      "section": "Section 5: Liabilities",
      "subSection": "b) Genetic",
      "questionBody": "Does the Mtb genome contain functionally redundant genes of this target?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "02f742df-3af2-4930-b1d9-2e811e070afa",
          "answer": "NO",
          "description": "The Mtb genome does not contain functionally redundant genes.",
          "isInverted": null,
          "weight": 1,
          "id": "c092ce4d-28f1-4bb5-ad8d-8669f2751258",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "02f742df-3af2-4930-b1d9-2e811e070afa",
          "answer": "UNKNOWN",
          "description": "The submitter has insufficient knowledge on this question.",
          "isInverted": null,
          "weight": 1,
          "id": "7b57e573-eb6f-49c3-acbf-6b5092eb0814",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "02f742df-3af2-4930-b1d9-2e811e070afa",
          "answer": "YES",
          "description": "The Mtb genome contains functionally redundant genes.",
          "isInverted": null,
          "weight": 0.7,
          "id": "18da1ce2-b4ad-4337-995e-409c7ac86744",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "02f742df-3af2-4930-b1d9-2e811e070afa",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "5B1",
      "module": "TargetPromotionQuestions",
      "section": "Section 5: Liabilities",
      "subSection": "c) Other",
      "sectionDescription": "",
      "questionBody": "Does the Mtb genome contain functionally redundant genes of this target?",

      "toolTip": "",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "c401e18d-a457-4c9c-981a-0e79cb9e27e1",
          "answer": "UNKNOWN",
          "description": "The submitter has insufficient knowledge on this question.",
          "isInverted": null,
          "weight": 1,
          "id": "9d72eb0d-a36b-4e94-a0ed-5d6b86c7e50b",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "c401e18d-a457-4c9c-981a-0e79cb9e27e1",
          "answer": "YES",
          "description": "Inhibitors with low cellular toxicity have been identified.  Alternatively, the protein does contain an active or allosteric site that is different than the human ortholog.",
          "isInverted": null,
          "weight": 1,
          "id": "aa5a236f-4d7f-4e53-bf8c-47b0293f3dcc",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "c401e18d-a457-4c9c-981a-0e79cb9e27e1",
          "answer": "NO",
          "description": "The protein has an active or allosteric site that is similar to the human ortholog.",
          "isInverted": null,
          "weight": 0.5,
          "id": "d546d8c5-4bde-44ec-9e12-82bf469dcb39",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "c401e18d-a457-4c9c-981a-0e79cb9e27e1",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "6A1",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(a) High Throughput Screening Feasibility",
      "questionBody": "Can active protein be prepared in sufficient quantities?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "d61de17a-9ae9-4ad9-8694-fec0fe8ec88e",
          "answer": "UNKNOWN",
          "description": "The submitter has insufficient knowledge on this question or protein preparation on has not been attempted.",
          "isInverted": null,
          "weight": 0,
          "id": "b6667118-1e97-4320-8220-e631cc1d08e6",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "d61de17a-9ae9-4ad9-8694-fec0fe8ec88e",
          "answer": "NO",
          "description": "Attempts to prepare the protein have been unsuccessful.",
          "isInverted": null,
          "weight": 0,
          "id": "1a8b6ecf-9185-4739-93a7-50a08ab1d5d8",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "d61de17a-9ae9-4ad9-8694-fec0fe8ec88e",
          "answer": "YES",
          "description": "The protein can be prepared.",
          "isInverted": null,
          "weight": 2,
          "id": "5f31672b-6698-4203-a4b5-f49e1d1a4529",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "d61de17a-9ae9-4ad9-8694-fec0fe8ec88e",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "6A2",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(a) High Throughput Screening Feasibility",
      "questionBody": "Has an assay for this target been enabled?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "35cc2d49-99d0-4f5f-a727-b5d53516a26b",
          "answer": "YES",
          "description": "An assay for Mtb protein has been established.",
          "isInverted": null,
          "weight": 2,
          "id": "b4334e9e-5e27-4963-9f6e-d1383866c648",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "35cc2d49-99d0-4f5f-a727-b5d53516a26b",
          "answer": "UNKNOWN",
          "description": "The submitter has insufficient knowledge on this question.  Alternatively, an assay for this protein has not been attempted.",
          "isInverted": null,
          "weight": 0,
          "id": "0700fa3b-c7ee-4c0b-906b-5bbe5f39cf1f",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "35cc2d49-99d0-4f5f-a727-b5d53516a26b",
          "answer": "NO",
          "description": "An assay for Mtb protein has been attempted but has not been established.",
          "isInverted": null,
          "weight": 0,
          "id": "f5a76724-b50a-4be6-b82c-88c2da82a21a",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "35cc2d49-99d0-4f5f-a727-b5d53516a26b",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "6A3",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(a) High Throughput Screening Feasibility",
      "questionBody": "Has an assay been established for an ortholog of this target from another species?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "d2af875a-d73f-420e-9a3f-8a3bcc49c667",
          "answer": "UNKNOWN",
          "description": "The submitter has insufficient knowledge on this question.  Alternatively, an assay for this protein has not been attempted.",
          "isInverted": null,
          "weight": 0,
          "id": "47a207d1-462a-46e1-8567-15119e5a2dae",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "d2af875a-d73f-420e-9a3f-8a3bcc49c667",
          "answer": "NO",
          "description": "An assay for an ortholog has been attempted but has not been established.  Please provide details.",
          "isInverted": null,
          "weight": 0,
          "id": "d70204f5-be44-4c49-a60a-21345dda0dba",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "d2af875a-d73f-420e-9a3f-8a3bcc49c667",
          "answer": "YES",
          "description": "An assay for an ortholog has been established.  Please provide details.",
          "isInverted": null,
          "weight": 2,
          "id": "0fbbc55e-39ac-4e3f-97be-1d5a8e29ba14",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "d2af875a-d73f-420e-9a3f-8a3bcc49c667",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "6A4",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(a) High Throughput Screening Feasibility",
      "questionBody": "Is high throughput screening of this target possible?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "aeba11b0-fa36-4013-abf4-42861f2d54a1",
          "answer": "NO",
          "description": "Factors make HTS screening of this protein difficult or impossible (i.e., there is one or more \"no\" responses to the following sub questions). Please provide details.",
          "isInverted": null,
          "weight": 0,
          "id": "cac63c85-89f6-478b-a17f-1a8895d40b2b",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "aeba11b0-fa36-4013-abf4-42861f2d54a1",
          "answer": "UNKNOWN",
          "description": "The submitter has insufficient knowledge on this question.  Alternatively, a HTS screen for this protein has not been attempted.",
          "isInverted": null,
          "weight": 0,
          "id": "0ac53722-5b14-4181-8a27-8a2373c59e39",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "aeba11b0-fa36-4013-abf4-42861f2d54a1",
          "answer": "YES",
          "description": "An HTS screen has been performed.  Alternatively, answers to sub-questions indicate that screening is feasible. Please provide details.",
          "isInverted": null,
          "weight": 2,
          "id": "d67885c0-83a1-4f53-acd6-47b3147d770b",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "aeba11b0-fa36-4013-abf4-42861f2d54a1",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "6A4A",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(a) High Throughput Screening Feasibility",
      "questionBody": "Is protein available in sufficient quantity for high throughput screening?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "e0c572fc-9d15-4690-ad62-2760013761b7",
          "answer": "UNKNOWN",
          "description": "The submitter has insufficient knowledge on this question.",
          "isInverted": null,
          "weight": 0,
          "id": "0788172a-c1f3-409a-b858-cb0c27f3d982",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "e0c572fc-9d15-4690-ad62-2760013761b7",
          "answer": "YES",
          "description": "Methods to prepare sufficient quantity of protein are available.",
          "isInverted": null,
          "weight": 2,
          "id": "44baad41-4342-4084-8091-15ecd453fed2",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "e0c572fc-9d15-4690-ad62-2760013761b7",
          "answer": "NO",
          "description": "Methods to prepare sufficient quantity of protein are not available.",
          "isInverted": null,
          "weight": 0,
          "id": "0346d89f-b72a-40dd-b344-e40efdb04d51",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "e0c572fc-9d15-4690-ad62-2760013761b7",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "6A4B",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(a) High Throughput Screening Feasibility",
      "questionBody": "Are the known assays for this target appropriate for high throughput screening?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "49aadc56-3078-49a1-ac8a-33671ad5cc49",
          "answer": "YES",
          "description": "Assay type is a member of the following list.",
          "isInverted": null,
          "weight": 2,
          "id": "175714fa-a4b3-410e-b1e6-c5359fccd4bb",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "49aadc56-3078-49a1-ac8a-33671ad5cc49",
          "answer": "UNKNOWN",
          "description": "The submitter has insufficient knowledge on this question.",
          "isInverted": null,
          "weight": 0,
          "id": "b1ecdb4c-dc96-45cb-8e13-bc266f47a59d",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "49aadc56-3078-49a1-ac8a-33671ad5cc49",
          "answer": "NO",
          "description": "Assay type is not a member of the following list.",
          "isInverted": null,
          "weight": 0,
          "id": "0b012f5f-04cf-4468-8f66-062f51874069",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "49aadc56-3078-49a1-ac8a-33671ad5cc49",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "6A4C",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(a) High Throughput Screening Feasibility",
      "questionBody": "Are there any logistical impediments to high throughput screening of this target?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "0d493be4-7dd9-40bd-b683-929729fca7be",
          "answer": "UNKNOWN",
          "description": "The submitter has insufficient knowledge on this question.",
          "isInverted": null,
          "weight": 0,
          "id": "67200b85-4a13-4559-8046-8a4d7f8de87c",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "0d493be4-7dd9-40bd-b683-929729fca7be",
          "answer": "YES",
          "description": "There are no impediments.",
          "isInverted": null,
          "weight": -2,
          "id": "93d10d19-e13d-455b-ad9f-b32bcc83756e",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "0d493be4-7dd9-40bd-b683-929729fca7be",
          "answer": "NO",
          "description": "There are impediments.",
          "isInverted": null,
          "weight": 4,
          "id": "7c0e7a9c-d840-4b9b-afb0-2207383c9556",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "0d493be4-7dd9-40bd-b683-929729fca7be",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "6A5",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(a) High Throughput Screening Feasibility",
      "sectionDescription": "",
      "questionBody": "Has small scale screening against this target been performed?",

      "toolTip": "",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "7d864773-d8d9-4962-8763-ccdea030e6b7",
          "answer": "NO",
          "description": "Attempts to setup small-scale screens were unsuccessful.",
          "isInverted": null,
          "weight": 0,
          "id": "8d6d7cff-50c7-4a9b-8fa9-60d25ed9118b",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "7d864773-d8d9-4962-8763-ccdea030e6b7",
          "answer": "YES",
          "description": "A small scale screen has been performed.",
          "isInverted": null,
          "weight": 1,
          "id": "3018a818-44bb-4359-9481-45ce5b5a05e5",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "7d864773-d8d9-4962-8763-ccdea030e6b7",
          "answer": "UNKNOWN",
          "description": "The submitter has insufficient knowledge on this question.  Alternatively, a small-scale screen for this protein has not been attempted.",
          "isInverted": null,
          "weight": 0,
          "id": "81735a9d-c6d8-4470-a25c-0710a624bd81",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "7d864773-d8d9-4962-8763-ccdea030e6b7",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "6A6",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(a) High Throughput Screening Feasibility",
      "questionBody": "Have large scale screens against this target been performed?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "84c83c3c-a14b-4111-89b8-c9a351b95dea",
          "answer": "YES",
          "description": "A large-scale16 screen has been performed. Please provide details.",
          "isInverted": null,
          "weight": 2,
          "id": "f6f2014b-6650-448e-a4d1-7eacaa48b204",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "84c83c3c-a14b-4111-89b8-c9a351b95dea",
          "answer": "NO",
          "description": "Attempts to run a large-scale16 screen were unsuccessful. Please provide details.",
          "isInverted": null,
          "weight": 0,
          "id": "6b180d3c-133b-4b79-b3b2-3a9506677697",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "84c83c3c-a14b-4111-89b8-c9a351b95dea",
          "answer": "UNKNOWN",
          "description": "The submitter has insufficient knowledge on this question. Alternatively, a large-scale screen for this protein has not been attempted.",
          "isInverted": null,
          "weight": 0,
          "id": "8d84d49e-406a-4abd-8693-4894b15ff3f5",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "84c83c3c-a14b-4111-89b8-c9a351b95dea",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "6A6A",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(a) High Throughput Screening Feasibility",
      "questionBody": "Have multiple unsuccessful screens against target this target been run?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "3190e9be-b0ab-4efb-bd79-4dc3892605ec",
          "answer": "YES",
          "description": "There have been multiple unsuccessful large-scale screens run against this target.",
          "isInverted": null,
          "weight": -4,
          "id": "372aaff7-2c51-4575-bbf7-f71b66f36941",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "3190e9be-b0ab-4efb-bd79-4dc3892605ec",
          "answer": "NO",
          "description": "There have not been multiple unsuccessful large-scale screens run against this target.",
          "isInverted": null,
          "weight": 0,
          "id": "9b3c3e4b-5405-4793-80af-9534681683ad",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "3190e9be-b0ab-4efb-bd79-4dc3892605ec",
          "answer": "UNKNOWN",
          "description": "It is not known whether multiple unsuccessful large-scale screens have been run against this target.",
          "isInverted": null,
          "weight": 0,
          "id": "2b0e191a-4910-4020-b262-0b9fc6e4bce0",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "3190e9be-b0ab-4efb-bd79-4dc3892605ec",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "6A7",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(a) High Throughput Screening Feasibility",
      "sectionDescription": "",
      "questionBody": "Have hits been identified from a High Throughput Screen (HTS) of  this target?",
      "toolTip": "",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "3d2ba995-e97e-4dac-9dd8-84d4e5de88ed",
          "answer": "UNKNOWN",
          "description": "Binding studies have not been undertaken on compounds that are thought to engage1 the target.  Alternatively, binding studies on compounds that are thought to engage1 the target are inconclusive.  Please describe type of study.",
          "isInverted": null,
          "weight": 0,
          "id": "2de8fc3b-743d-4757-a767-8096e5dd0206",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "3d2ba995-e97e-4dac-9dd8-84d4e5de88ed",
          "answer": "YES",
          "description": "Compounds bind purified target. Please describe type of study.",
          "isInverted": null,
          "weight": 5,
          "id": "0f287415-56b7-4539-a06a-019eb37d263e",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "3d2ba995-e97e-4dac-9dd8-84d4e5de88ed",
          "answer": "NO",
          "description": "Compounds do not bind purified target. Please describe type of study.",
          "isInverted": null,
          "weight": 0,
          "id": "40882978-8e77-4dd7-a36c-0fdf6938741d",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "3d2ba995-e97e-4dac-9dd8-84d4e5de88ed",
      "isArchived": false,
      "isDeleted": false
    },
    

    {
      "identification": "6B1D",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(b) Structure Based Feasibility",
      "questionBody": "Has this target undergone successful structure based design efforts?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "6d76648a-756e-4d0c-8751-a6be41c42e0a",
          "answer": "YES",
          "description": "A successful structure-based design effort has been performed.",
          "isInverted": null,
          "weight": 6,
          "id": "35993d99-30a2-481f-8ca8-0e4d09fba898",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "6d76648a-756e-4d0c-8751-a6be41c42e0a",
          "answer": "NO",
          "description": "Attempts to perform structure-based design were unsuccessful.",
          "isInverted": null,
          "weight": 0,
          "id": "612b5137-6935-4a41-a3e4-161a8ff33c01",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "6d76648a-756e-4d0c-8751-a6be41c42e0a",
          "answer": "UNKNOWN",
          "description": "The submitter has insufficient knowledge on this question.",
          "isInverted": null,
          "weight": 0,
          "id": "2a196b80-687b-4587-8c64-c26953e82aaf",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "6d76648a-756e-4d0c-8751-a6be41c42e0a",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "6B1A",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(b) Structure Based Feasibility",
      "questionBody": "Is there a structure available for this target?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "626cb147-8cf5-494b-a23e-b08e85c7eec7",
          "answer": "YES",
          "description": "",
          "isInverted": null,
          "weight": 2,
          "id": "5ec26d70-dbef-4e0f-be01-c8682bad0a3b",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "626cb147-8cf5-494b-a23e-b08e85c7eec7",
          "answer": "NO",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "9bd3361a-66b4-4deb-af91-ce3b0e312143",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "626cb147-8cf5-494b-a23e-b08e85c7eec7",
          "answer": "UNKNOWN",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "6cce8f65-28a2-4037-9d1d-3416cb62bd5f",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "626cb147-8cf5-494b-a23e-b08e85c7eec7",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "6B1B1",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(b) Structure Based Feasibility",
      "questionBody": "If yes, does the structure have a bound ligand?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "f1e2e3e4-3c7b-4d0e-8f3a-2c3e5f6a7b8c",
          "answer": "YES",
          "description": "",
          "isInverted": null,
          "weight": 1,
          "id": "c8f8e8d8-9f9f-4f4f-8f8f-7e7e6e6e6e6e",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "f1e2e3e4-3c7b-4d0e-8f3a-2c3e5f6a7b8c",
          "answer": "NO",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "b7b7b7b7-8e8e-4d4d-9d9d-6c6c5c5c5c5c",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "f1e2e3e4-3c7b-4d0e-8f3a-2c3e5f6a7b8c",
          "answer": "UNKNOWN",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "a6a6a6a6-7d7d-4c4c-a4a4-5b5b4b4b4b4b",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "f1e2e3e4-3c7b-4d0e-8f3a-2c3e5f6a7b8c",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "6B1B2",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(b) Structure Based Feasibility",
      "questionBody": "If yes, is the ligand drug like?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "d2c3b4a5-6e7f-8g9h-0i1j-2k3l4m5n6o7p",
          "answer": "YES",
          "description": "",
          "isInverted": null,
          "weight": 2,
          "id": "e1f2g3h4-i5j6-k7l8-m9n0-o1p2q3r4s5t6",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "d2c3b4a5-6e7f-8g9h-0i1j-2k3l4m5n6o7p",
          "answer": "NO",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "f7g8h9i0-j1k2-l3m4-n5o6-p7q8r9s0t1u2",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "d2c3b4a5-6e7f-8g9h-0i1j-2k3l4m5n6o7p",
          "answer": "UNKNOWN",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "g9h0i1j2-k3l4-m5n6-o7p8-q9r0s1t2u3v4",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "d2c3b4a5-6e7f-8g9h-0i1j-2k3l4m5n6o7p",
      "isArchived": false,
      "isDeleted": false
    },

    {
      "identification": "6B2A",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(b) Structure Based Feasibility",
      "questionBody": "If yes, is the structure <2.8 â« resolution?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "c1e2f3a4-b5c6-d7e8-f9g0-h1i2j3k4l5m6",
          "answer": "YES",
          "description": "",
          "isInverted": null,
          "weight": 2,
          "id": "n7o8p9q0-r1s2-t3u4-v5w6-x7y8z9a0b1c2",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "c1e2f3a4-b5c6-d7e8-f9g0-h1i2j3k4l5m6",
          "answer": "NO",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "d3e4f5g6-h7i8-j9k0-l1m2-n3o4p5q6r7s8",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "c1e2f3a4-b5c6-d7e8-f9g0-h1i2j3k4l5m6",
          "answer": "UNKNOWN",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "t9u0v1w2-x3y4-z5a6-b7c8-d9e0f1g2h3i4",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "c1e2f3a4-b5c6-d7e8-f9g0-h1i2j3k4l5m6",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "6B2B",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(b) Structure Based Feasibility",
      "questionBody": "Is there an apo structure with <2.8 â« resolution?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "e5f6g7h8-i9j0-k1l2-m3n4-o5p6q7r8s9t0",
          "answer": "YES",
          "description": "",
          "isInverted": null,
          "weight": 1,
          "id": "u1v2w3x4-y5z6-a7b8-c9d0-e1f2g3h4i5j6",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "e5f6g7h8-i9j0-k1l2-m3n4-o5p6q7r8s9t0",
          "answer": "NO",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "k7l8m9n0-o1p2-q3r4-s5t6-u7v8w9x0y1z2",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "e5f6g7h8-i9j0-k1l2-m3n4-o5p6q7r8s9t0",
          "answer": "UNKNOWN",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "a3b4c5d6-e7f8-g9h0-i1j2-k3l4m5n6o7p8",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "e5f6g7h8-i9j0-k1l2-m3n4-o5p6q7r8s9t0",
      "isArchived": false,
      "isDeleted": false
    },

    {
      "identification": "6B2C",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(b) Structure Based Feasibility",
      "questionBody": "Are there multiple structure available?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "f1g2h3i4-j5k6-l7m8-n9o0-p1q2r3s4t5u6",
          "answer": "YES",
          "description": "",
          "isInverted": null,
          "weight": 2,
          "id": "v7w8x9y0-z1a2-b3c4-d5e6-f7g8h9i0j1k2",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "f1g2h3i4-j5k6-l7m8-n9o0-p1q2r3s4t5u6",
          "answer": "NO",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "l3m4n5o6-p7q8-r9s0-t1u2-v3w4x5y6z7a8",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "f1g2h3i4-j5k6-l7m8-n9o0-p1q2r3s4t5u6",
          "answer": "UNKNOWN",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "b9c0d1e2-f3g4-h5i6-j7k8-l9m0n1o2p3q4",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "f1g2h3i4-j5k6-l7m8-n9o0-p1q2r3s4t5u6",
      "isArchived": false,
      "isDeleted": false
    },

    
    {
      "identification": "6B3D",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(b) Structure Based Feasibility",
      "sectionDescription": "",
      "questionBody": "Has an ortholog of this target undergone successful structure based design efforts?",
      "toolTip": "",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "74b0d245-d2f8-467d-b677-f34b35dd5d9e",
          "answer": "YES",
          "description": "",
          "isInverted": null,
          "weight": 4,
          "id": "c9759129-3010-415e-af05-874546cbb879",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "74b0d245-d2f8-467d-b677-f34b35dd5d9e",
          "answer": "NO",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "9bc8e45e-2d0d-41fd-88b0-15aa5a7e7b5a",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "74b0d245-d2f8-467d-b677-f34b35dd5d9e",
          "answer": "UNKNOWN",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "b1f3c6e7-8d9a-4b0c-9e1f-2a3b4c5d6e7f",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "74b0d245-d2f8-467d-b677-f34b35dd5d9e",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "6B3A",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(b) Structure Based Feasibility",
      "questionBody": "Is there a structure available for an ortholog of this target?",
      "toolTip": "",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "d3e4f5a6-b7c8-9d0e-f1g2-h3i4j5k6l7m8",
          "answer": "YES",
          "description": "",
          "isInverted": null,
          "weight": 1,
          "id": "n8o9p0q1-r2s3-t4u5-v6w7-x8y9z0a1b2c3",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "d3e4f5a6-b7c8-9d0e-f1g2-h3i4j5k6l7m8",
          "answer": "NO",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "d4e5f6g7-h8i9-j0k1-l2m3-n4o5p6q7r8s9",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "d3e4f5a6-b7c8-9d0e-f1g2-h3i4j5k6l7m8",
          "answer": "UNKNOWN",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "t0u1v2w3-x4y5-z6a7-b8c9-d0e1f2g3h4i5",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "d3e4f5a6-b7c8-9d0e-f1g2-h3i4j5k6l7m8",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "6B3B1",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(b) Structure Based Feasibility",
      "questionBody": "If yes, does the structure have a bound ligand?",
      "toolTip": "",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "a1b2c3d4-e5f6-7g8h-9i0j-k1l2m3n4o5p6",
          "answer": "YES",
          "description": "",
          "isInverted": null,
          "weight": 1,
          "id": "q7r8s9t0-u1v2-w3x4-y5z6-a7b8c9d0e1f2",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "a1b2c3d4-e5f6-7g8h-9i0j-k1l2m3n4o5p6",
          "answer": "NO",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "g3h4i5j6-k7l8-m9n0-o1p2-q3r4s5t6u7v8",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "a1b2c3d4-e5f6-7g8h-9i0j-k1l2m3n4o5p6",
          "answer": "UNKNOWN",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "w9x0y1z2-a3b4-c5d6-e7f8-g9h0i1j2k3l4",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "a1b2c3d4-e5f6-7g8h-9i0j-k1l2m3n4o5p6",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "6B3B2",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(b) Structure Based Feasibility",
      "questionBody": "If yes, is the ligand drug like?",
      "toolTip": "",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "m5n6o7p8-q9r0-s1t2-u3v4-w5x6y7z8a9b0",
          "answer": "YES",
          "description": "",
          "isInverted": null,
          "weight": 1,
          "id": "c1d2e3f4-g5h6-i7j8-k9l0-m1n2o3p4q5r6",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "m5n6o7p8-q9r0-s1t2-u3v4-w5x6y7z8a9b0",
          "answer": "NO",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "s7t8u9v0-w1x2-y3z4-a5b6-c7d8e9f0g1h2",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "m5n6o7p8-q9r0-s1t2-u3v4-w5x6y7z8a9b0",
          "answer": "UNKNOWN",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "i3j4k5l6-m7n8-o9p0-q1r2-s3t4u5v6w7x8",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "m5n6o7p8-q9r0-s1t2-u3v4-w5x6y7z8a9b0",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "6B4A",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(b) Structure Based Feasibility",
      "questionBody": "If yes, is the structure <2.8 â« resolution?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "b1c2d3e4-f5g6-h7i8-j9k0-l1m2n3o4p5q6",
          "answer": "YES",
          "description": "",
          "isInverted": null,
          "weight": 1,
          "id": "r7s8t9u0-v1w2-x3y4-z5a6-b7c8d9e0f1g2",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "b1c2d3e4-f5g6-h7i8-j9k0-l1m2n3o4p5q6",
          "answer": "NO",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "h3i4j5k6-l7m8-n9o0-p1q2-r3s4t5u6v7w8",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "b1c2d3e4-f5g6-h7i8-j9k0-l1m2n3o4p5q6",
          "answer": "UNKNOWN",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "x9y0z1a2-b3c4-d5e6-f7g8-h9i0j1k2l3m4",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "b1c2d3e4-f5g6-h7i8-j9k0-l1m2n3o4p5q6",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "6B4B",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(b) Structure Based Feasibility",
      "questionBody": "Is there an apo structure with <2.8 â« resolution?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "c3d4e5f6-g7h8-i9j0-k1l2-m3n4o5p6q7r8",
          "answer": "YES",
          "description": "",
          "isInverted": null,
          "weight": 1,
          "id": "r9s0t1u2-v3w4-x5y6-z7a8-b9c0d1e2f3g4",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "c3d4e5f6-g7h8-i9j0-k1l2-m3n4o5p6q7r8",
          "answer": "NO",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "h5i6j7k8-l9m0-n1o2-p3q4-r5s6t7u8v9w0",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "c3d4e5f6-g7h8-i9j0-k1l2-m3n4o5p6q7r8",
          "answer": "UNKNOWN",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "x1y2z3a4-b5c6-d7e8-f9g0-h1i2j3k4l5m6",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "c3d4e5f6-g7h8-i9j0-k1l2-m3n4o5p6q7r8",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "6B4C",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(b) Structure Based Feasibility",
      "questionBody": "Are there multiple structure available?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "d5e6f7g8-h9i0-j1k2-l3m4-n5o6p7q8r9s0",
          "answer": "YES",
          "description": "",
          "isInverted": null,
          "weight": 1,
          "id": "t1u2v3w4-x5y6-z7a8-b9c0-d1e2f3g4h5i6",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "d5e6f7g8-h9i0-j1k2-l3m4-n5o6p7q8r9s0",
          "answer": "NO",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "j7k8l9m0-n1o2-p3q4-r5s6-t7u8v9w0x1y2",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "d5e6f7g8-h9i0-j1k2-l3m4-n5o6p7q8r9s0",
          "answer": "UNKNOWN",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "z3a4b5c6-d7e8-f9g0-h1i2-j3k4l5m6n7o8",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "d5e6f7g8-h9i0-j1k2-l3m4-n5o6p7q8r9s0",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "6B3C1",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(b) Structure Based Feasibility",
      "questionBody": "Is the protein amino acid identity > 60% for this ortholog?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "e7f8g9h0-i1j2-k3l4-m5n6-o7p8q9r0s1t2",
          "answer": "YES",
          "description": "",
          "isInverted": null,
          "weight": 1,
          "id": "u3v4w5x6-y7z8-a9b0-c1d2-e3f4g5h6i7j8",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "e7f8g9h0-i1j2-k3l4-m5n6-o7p8q9r0s1t2",
          "answer": "NO",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "k9l0m1n2-o3p4-q5r6-s7t8-u9v0w1x2y3z4",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "e7f8g9h0-i1j2-k3l4-m5n6-o7p8q9r0s1t2",
          "answer": "UNKNOWN",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "a5b6c7d8-e9f0-g1h2-i3j4-k5l6m7n8o9p0",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "e7f8g9h0-i1j2-k3l4-m5n6-o7p8q9r0s1t2",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "6B3C2",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(b) Structure Based Feasibility",
      "questionBody": "Is the ortholog from a mycobacterium species?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "e7f8g9h0-i1j2-k3l4-m5n6-o7p8q9r0s1t2",
          "answer": "YES",
          "description": "",
          "isInverted": null,
          "weight": 1,
          "id": "u3v4w5x6-y7z8-a9b0-c1d2-e3f4g5h6i7j8",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "e7f8g9h0-i1j2-k3l4-m5n6-o7p8q9r0s1t2",
          "answer": "NO",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "k9l0m1n2-o3p4-q5r6-s7t8-u9v0w1x2y3z4",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "e7f8g9h0-i1j2-k3l4-m5n6-o7p8q9r0s1t2",
          "answer": "UNKNOWN",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "a5b6c7d8-e9f0-g1h2-i3j4-k5l6m7n8o9p0",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "e7f8g9h0-i1j2-k3l4-m5n6-o7p8q9r0s1t2",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "6B5A",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(b) Structure Based Feasibility",
      "sectionDescription": "",
      "questionBody": "What is the druggability of the binding pocket of this target?",
      "toolTip": "",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "cae72771-039e-45e2-9d6f-1dd59e1a34fe",
          "answer": "HIGH",
          "description": "",
          "isInverted": null,
          "weight": 5,
          "id": "5ca84d27-722b-4e8f-bd39-b66fd9a4fa42",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "cae72771-039e-45e2-9d6f-1dd59e1a34fe",
          "answer": "MEDIUM",
          "description": "",
          "isInverted": null,
          "weight": 3,
          "id": "ef7b5f19-d103-4e26-b9be-f6092521da36",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "cae72771-039e-45e2-9d6f-1dd59e1a34fe",
          "answer": "LOW",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "3fa54dab-f504-4b16-98fe-750b6bbe4e99",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "cae72771-039e-45e2-9d6f-1dd59e1a34fe",
          "answer": "N/A",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "d78f7649-4041-40d9-8904-7088b1a2436b",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "cae72771-039e-45e2-9d6f-1dd59e1a34fe",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "6B5B",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(b) Structure Based Feasibility",
      "questionBody": "What is the druggability of the binding pocket of the ortholog of this target?",
      "toolTip": "",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "f1e2d3c4-b5a6-7980-1a2b-3c4d5e6f7g8h",
          "answer": "HIGH",
          "description": "",
          "isInverted": null,
          "weight": 3,
          "id": "h9i0j1k2-l3m4-n5o6-p7q8-r9s0t1u2v3w4",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "f1e2d3c4-b5a6-7980-1a2b-3c4d5e6f7g8h",
          "answer": "MEDIUM",
          "description": "",
          "isInverted": null,
          "weight": 3,
          "id": "x5y6z7a8-b9c0-d1e2-f3g4-h5i6j7k8l9m0",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "f1e2d3c4-b5a6-7980-1a2b-3c4d5e6f7g8h",
          "answer": "LOW",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "n1o2p3q4-r5s6-t7u8-v9w0-x1y2z3a4b5c6",
          "isArchived": false,
          "isDeleted": false
        }
        {
          "questionId": "f1e2d3c4-b5a6-7980-1a2b-3c4d5e6f7g8h",
          "answer": "N/A",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "d7e8f9g0-h1i2-j3k4-l5m6-n7o8p9q0r1s2",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "f1e2d3c4-b5a6-7980-1a2b-3c4d5e6f7g8h",
      "isArchived": false,
      "isDeleted": false
    },

    {
      "identification": "6C6",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(c) Progressibility of compounds",
      "questionBody": "How far have compounds with confirmed on-target whole cell activity advanced down the drug discovery/development pipeline?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "118da8fc-8f62-4fbd-9b30-8c95a4e3c48a",
          "answer": "NONE",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "f4c3b2a1-0e9d-8c7b-6a5f-4e3d2c1b0a9f",
          "isArchived": false,
          "isDeleted": false
        },
        
        {
          "questionId": "118da8fc-8f62-4fbd-9b30-8c95a4e3c48a",
          "answer": "SCREENING HIT",
          "description": "",
          "isInverted": null,
          "weight": 3,
          "id": "a11f93c7-f827-4da4-bc67-067cb492a1ca",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "118da8fc-8f62-4fbd-9b30-8c95a4e3c48a",
          "answer": "HA",
          "description": "",
          "isInverted": null,
          "weight": 4,
          "id": "db8d2961-62b0-4b97-b1db-3bacbb05113b",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "118da8fc-8f62-4fbd-9b30-8c95a4e3c48a",
          "answer": "H2L",
          "description": "",
          "isInverted": null,
          "weight": 5,
          "id": "b58eeb03-e0b1-4ffe-8d81-e5f63beee66b",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "118da8fc-8f62-4fbd-9b30-8c95a4e3c48a",
          "answer": "LO",
          "description": "",
          "isInverted": null,
          "weight": 6,
          "id": "883a18ad-617d-47d7-84a1-3e7b3ce8cbc6",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "118da8fc-8f62-4fbd-9b30-8c95a4e3c48a",
          "answer": "SP",
          "description": "",
          "isInverted": null,
          "weight": 7,
          "id": "437cb6d6-ae36-4939-bb75-5d0ea1ca0ba2",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "118da8fc-8f62-4fbd-9b30-8c95a4e3c48a",
          "answer": "Candidate",
          "description": "",
          "isInverted": null,
          "weight": 8,
          "id": "50a6fe29-1534-4463-b3b5-e1ae7f940cd9",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "118da8fc-8f62-4fbd-9b30-8c95a4e3c48a",
          "answer": "CLINIC",
          "description": "",
          "isInverted": null,
          "weight": 9,
          "id": "a93bb085-31fb-4caf-8961-30ff70e4f279",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "118da8fc-8f62-4fbd-9b30-8c95a4e3c48a",
          "answer": "DRUG",
          "description": "",
          "isInverted": null,
          "weight": 10,
          "id": "3f29d15b-1989-4751-a705-55c4f29aa948",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "118da8fc-8f62-4fbd-9b30-8c95a4e3c48a",
      "isArchived": false,
      "isDeleted": false
    },

    {
      "identification": "6C7",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(d) Safety Considerations",
      "questionBody": "Is the class of proteins this target is a member of considered druggable?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "a9b8c7d6-e5f4-3210-9a8b-7c6d5e4f3g2h",
          "answer": "DEFINITELY",
          "description": "",
          "isInverted": null,
          "weight": 5,
          "id": "1h2g3f4e-5d6c-7b8a-9a0b-1c2d3e4f5g6h",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "a9b8c7d6-e5f4-3210-9a8b-7c6d5e4f3g2h",
          "answer": "PROBABLY",
          "description": "It is unknown whether the human ortholog is essential in a relevant cell line or animal model.",
          "isInverted": null,
          "weight": 2.4,
          "id": "7g6f5e4d-3c2b-1a0b-9a8b-7c6d5e4f3g2h",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "a9b8c7d6-e5f4-3210-9a8b-7c6d5e4f3g2h",
          "answer": "UNLIKELY",
          "description": "",
          "isInverted": null,
          "weight": 1,
          "id": "5f4e3d2c-1b0a-9a8b-7c6d-5e4f3g2h1i0j",
          "isArchived": false,
          "isDeleted": false  
        },
        {
          "questionId": "a9b8c7d6-e5f4-3210-9a8b-7c6d5e4f3g2h",
          "answer": "NO",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "h9g8f7e6-d5c4-b3a2-1a0b-9c8d7e6f5g4h",
          "isArchived": false,
          "isDeleted": false
        }
      ]
    },

    {
      "identification": "6C3",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(d) Safety Considerations",
      "questionBody": "Have Inhibitors of orthologs of this target have been identified?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "3c9e8f7a-6b5c-4d3e-2f1g-0h9i8j7k6l5m",
          "answer": "YES",
          "description": "",
          "isInverted": null,
          "weight": 1,
          "id": "r7s8t9u0-v1w2-x3y4-z5a6-b7c8d9e0f1g2",
          "isArchived": false,
          "isDeleted": false  
        },
        {
          "questionId": "3c9e8f7a-6b5c-4d3e-2f1g-0h9i8j7k6l5m",
          "answer": "NO",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "5m6l7k8j-9i0h-g1f2-e3d4-c5b6a7n8o9p0",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "3c9e8f7a-6b5c-4d3e-2f1g-0h9i8j7k6l5m",
          "answer": "UNKNOWN",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "q1p2o3n4-m5l6-k7j8-i9h0-g1f2e3d4c5b6",
          "isArchived": false,
          "isDeleted": false
        }
        
      ]
    },
    {
      "identification": "6C4",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(d) Safety Considerations",
      "questionBody": "Are Drugs targeting orthologs of this target are known?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
         {
          "questionId": "d4e5f6g7-h8i9-j0k1-l2m3-n4o5p6q7r8s9",
          "answer": "YES",
          "description": "",
          "isInverted": null,
          "weight": 2,
          "id": "x3y4z5a6-b7c8-d9e0-f1g2-h3i4j5k6l7m8",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "d4e5f6g7-h8i9-j0k1-l2m3-n4o5p6q7r8s9",
          "answer": "NO",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "t1u2v3w4-x5y6-z7a8-b9c0-d1e2f3g4h5i6",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "d4e5f6g7-h8i9-j0k1-l2m3-n4o5p6q7r8s9",
          "answer": "UNKNOWN",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "j7k8l9m0-n1o2-p3q4-r5s6-t7u8v9w0x1y2",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "d4e5f6g7-h8i9-j0k1-l2m3-n4o5p6q7r8s9",
      "isArchived": false,
      "isDeleted": false
    },

    {
      "identification": "6C5B",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(d) Safety Considerations",
      "questionBody": "How druglike are compounds that show on-target whole cell activity against this target?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "9a8b7c6d-5e4f-3g2h-1i0j-9k8l7m6n5o4p",
          "answer": "HIGH",
          "description": "",
          "isInverted": null,
          "weight": 4,
          "id": "q1p2o3n4-m5l6-k7j8-i9h0-g1f2e3d4c5b6",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "9a8b7c6d-5e4f-3g2h-1i0j-9k8l7m6n5o4p",
          "answer": "MEDIUM",
          "description": "",
          "isInverted": null,
          "weight": 2,
          "id": "5m6l7k8j-9i0h-g1f2-e3d4-c5b6a7n8o9p0",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "9a8b7c6d-5e4f-3g2h-1i0j-9k8l7m6n5o4p",
          "answer": "LOW",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "r7s8t9u0-v1w2-x3y4-z5a6-b7c8d9e0f1g2",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "9a8b7c6d-5e4f-3g2h-1i0j-9k8l7m6n5o4p",
          "answer": "N/A",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "5f4e3d2c-1b0a-9a8b-7c6d-5e4f3g2h1i0j",
          "isArchived": false,
          "isDeleted": false
        }

      ],
      "id": "9a8b7c6d-5e4f-3g2h-1i0j-9k8l7m6n5o4p",
      "isArchived": false,
      "isDeleted": false  
    },

    {
      "identification": "6D1",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(d) Safety Considerations",
      "questionBody": "Does the human genome encode a structurally similar counterpart to this target?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "c3b2a1f0-e9d8-c7b6-a5f4-3e2d1c0b9a8f",
          "answer": "YES",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "d09e8f7g-6h5i-4j3k-2l1m-0n9o8p7q6r5s",
          "isArchived": false,
          "isDeleted": false
        }
        {
          "questionId": "c3b2a1f0-e9d8-c7b6-a5f4-3e2d1c0b9a8f",
          "answer": "NO",
          "description": "",
          "isInverted": null,
          "weight": 6,
          "id": "0a9b8c7d-6e5f-4g3h-2i1j-0k9l8m7n6o5p",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "c3b2a1f0-e9d8-c7b6-a5f4-3e2d1c0b9a8f",
          "answer": "UNKNOWN",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "4p5o6n7m-8l9k-0j1i-2h3g-4f5e6d7c8b9a",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "c3b2a1f0-e9d8-c7b6-a5f4-3e2d1c0b9a8f",
      "isArchived": false,
      "isDeleted": false
    },


    {
      "identification": "6D2",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(d) Safety Considerations",
      "questionBody": "Is the consequence of inhibiting the human ortholog to this target significant?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
          {
          "questionId": "f520aa0f-3b03-4397-91d3-a22554b9da91",
          "answer": "YES",
          "description": "The consequence of inhibiting the human ortholog is significant.",
          "isInverted": null,
          "weight": 0,
          "id": "042b689f-8f62-4254-9c02-8f2f9dec4ee6",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "f520aa0f-3b03-4397-91d3-a22554b9da91",
          "answer": "NO",
          "description": "The consequence of inhibiting the human ortholog is not significant.",
          "isInverted": null,
          "weight": 3,
          "id": "72e6d146-826e-4ab4-b5b5-f63dac6e2ea0",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "f520aa0f-3b03-4397-91d3-a22554b9da91",
          "answer": "UNKNOWN",
          "description": "It is unknown what the consequence of inhibiting the human ortholog is.",
          "isInverted": null,
          "weight": 0,
          "id": "df8ab74b-0ac3-4fb3-a344-49dce6697db3",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "f520aa0f-3b03-4397-91d3-a22554b9da91",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "6D4",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(d) Safety Considerations",
      "questionBody": "Are non-Mtb strains available which could be used to characterize compounds with broad spectrum activity?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "51a7d00f-2d4b-4f7b-b659-06216c4035a2",
          "answer": "YES",
          "description": "Mtb strains which could be used to characterize compounds with broad spectrum activity are available.",
          "isInverted": null,
          "weight": 1,
          "id": "9ebe4757-bdbb-431a-ae0d-56a857c88881",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "51a7d00f-2d4b-4f7b-b659-06216c4035a2",
          "answer": "NO",
          "description": "Mtb strains which could be used to characterize compounds with broad spectrum activity are not available.",
          "isInverted": null,
          "weight": 0,
          "id": "b3eb6500-a683-45a6-bfeb-e7484d6a7ead",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "51a7d00f-2d4b-4f7b-b659-06216c4035a2",
          "answer": "UNKNOWN",
          "description": "It is unknown whether Mtb strains which could be used to characterize compounds with broad spectrum activity are available.",
          "isInverted": null,
          "weight": 0,
          "id": "1bd1459e-22e5-408e-8937-6c40e5432b37",
          "isArchived": false,
          "isDeleted": false
        }
        
      ],
      "id": "51a7d00f-2d4b-4f7b-b659-06216c4035a2",
      "isArchived": false,
      "isDeleted": false
    },

    {
      "identification": "6D5A",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(d) Safety Considerations",
      "questionBody": "Have inhibitors been identified that do not inhibit or induce relevant human cytochrome p450s?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "d1e2f3g4-h5i6-j7k8-l9m0-n1o2p3q4r5s6",
          "answer": "YES",
          "description": "",
          "isInverted": null,
          "weight": 1,
          "id": "t6s5r4q3-p2o1-n0m9-l8k7-j6i5h4g3f2e1",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "d1e2f3g4-h5i6-j7k8-l9m0-n1o2p3q4r5s6",
          "answer": "NO",
          "description": "",
          "isInverted": null,
          "weight": 3,
          "id": "a1b2c3d4-e5f6-g7h8-i9j0-k1l2m3n4o5p6",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "d1e2f3g4-h5i6-j7k8-l9m0-n1o2p3q4r5s6",
          "answer": "UNKNOWN",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "q7p6o5n4-m3l2-k1j0-i9h8-g7f6e5d4c3b2",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "d1e2f3g4-h5i6-j7k8-l9m0-n1o2p3q4r5s6",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "6D5B",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(d) Safety Considerations",
      "questionBody": "Have inhibitors been identified that do not inhibit hERG or other human cardiac ion channels?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "a1b2c3d4-e5f6-g7h8-i9j0-k1l2m3n4o5p6",
          "answer": "YES",
          "description": "",
          "isInverted": null,
          "weight": 1,
          "id": "q7p6o5n4-m3l2-k1j0-i9h8-g7f6e5d4c3b2",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "a1b2c3d4-e5f6-g7h8-i9j0-k1l2m3n4o5p6",
          "answer": "NO",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "d1e2f3g4-h5i6-j7k8-l9m0-n1o2p3q4r5s6",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "a1b2c3d4-e5f6-g7h8-i9j0-k1l2m3n4o5p6",
          "answer": "UNKNOWN",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "t6s5r4q3-p2o1-n0m9-l8k7-j6i5h4g3f2e1",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "a1b2c3d4-e5f6-g7h8-i9j0-k1l2m3n4o5p6",
      "isArchived": false,
      "isDeleted": false    
    },
    {
      "identification": "6D5C",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(d) Safety Considerations",
      "questionBody": "Have inhibitors been identified that do not have in vitro genotox flags?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "e1f2g3h4-i5j6-k7l8-m9n0-o1p2q3r4s5t6",
          "answer": "YES",
          "description": "",
          "isInverted": null,
          "weight": 1,
          "id": "u6t5s4r3-q2p1-o0n9-m8l7-k6j5i4h3g2f1",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "e1f2g3h4-i5j6-k7l8-m9n0-o1p2q3r4s5t6",
          "answer": "NO",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "a1b2c3d4-e5f6-g7h8-i9j0-k1l2m3n4o5p6",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "e1f2g3h4-i5j6-k7l8-m9n0-o1p2q3r4s5t6",
          "answer": "UNKNOWN",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "q7p6o5n4-m3l2-k1j0-i9h8-g7f6e5d4c3b2",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "e1f2g3h4-i5j6-k7l8-m9n0-o1p2q3r4s5t6",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "6D5D",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(d) Safety Considerations",
      "questionBody": "Have inhibitors been identified that do not have AMES assay flags?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "b1c2d3e4-f5g6-h7i8-j9k0-l1m2n3o4p5q6",
          "answer": "YES",
          "description": "",
          "isInverted": null,
          "weight": 1,
          "id": "r6q5p4o3-n2m1-l0k9-j8i7-h6g5f4e3d2c1",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "b1c2d3e4-f5g6-h7i8-j9k0-l1m2n3o4p5q6",
          "answer": "NO",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "e1f2g3h4-i5j6-k7l8-m9n0-o1p2q3r4s5t6",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "b1c2d3e4-f5g6-h7i8-j9k0-l1m2n3o4p5q6",
          "answer": "UNKNOWN",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "u6t5s4r3-q2p1-o0n9-m8l7-k6j5i4h3g2f1",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "b1c2d3e4-f5g6-h7i8-j9k0-l1m2n3o4p5q6",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "6D5E",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(d) Safety Considerations",
      "questionBody": "Have inhibitors been identified that do not have micronucleus assay flags?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "g1h2i3j4-k5l6-m7n8-o9p0-q1r2s3t4u5v6",
          "answer": "YES",
          "description": "",
          "isInverted": null,
          "weight": 1,
          "id": "w6v5u4t3-s2r1-q0p9-o8n7-m6l5k4j3i2h1",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "g1h2i3j4-k5l6-m7n8-o9p0-q1r2s3t4u5v6",
          "answer": "NO",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "b1c2d3e4-f5g6-h7i8-j9k0-l1m2n3o4p5q6",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "g1h2i3j4-k5l6-m7n8-o9p0-q1r2s3t4u5v6",
          "answer": "UNKNOWN",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "r6q5p4o3-n2m1-l0k9-j8i7-h6g5f4e3d2c1",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "g1h2i3j4-k5l6-m7n8-o9p0-q1r2s3t4u5v6",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "6D5F",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(d) Safety Considerations",
      "questionBody": "Have inhibitors been identified that that were tolerable in an efficacy or pharmacokinetic animal study?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "g1h2i3j4-k5l6-m7n8-o9p0-q1r2s3t4u5v6",
          "answer": "YES",
          "description": "",
          "isInverted": null,
          "weight": 1,
          "id": "w6v5u4t3-s2r1-q0p9-o8n7-m6l5k4j3i2h1",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "g1h2i3j4-k5l6-m7n8-o9p0-q1r2s3t4u5v6",
          "answer": "NO",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "b1c2d3e4-f5g6-h7i8-j9k0-l1m2n3o4p5q6",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "g1h2i3j4-k5l6-m7n8-o9p0-q1r2s3t4u5v6",
          "answer": "UNKNOWN",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "r6q5p4o3-n2m1-l0k9-j8i7-h6g5f4e3d2c1",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "g1h2i3j4-k5l6-m7n8-o9p0-q1r2s3t4u5v6",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "6D5G",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(d) Safety Considerations",
      "questionBody": "Have inhibitors been identified that did not have significant findings in a rodent toxicology study?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "g1h2i3j4-k5l6-m7n8-o9p0-q1r2s3t4u5v6",
          "answer": "YES",
          "description": "",
          "isInverted": null,
          "weight": 1,
          "id": "w6v5u4t3-s2r1-q0p9-o8n7-m6l5k4j3i2h1",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "g1h2i3j4-k5l6-m7n8-o9p0-q1r2s3t4u5v6",
          "answer": "NO",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "b1c2d3e4-f5g6-h7i8-j9k0-l1m2n3o4p5q6",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "g1h2i3j4-k5l6-m7n8-o9p0-q1r2s3t4u5v6",
          "answer": "UNKNOWN",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "r6q5p4o3-n2m1-l0k9-j8i7-h6g5f4e3d2c1",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "g1h2i3j4-k5l6-m7n8-o9p0-q1r2s3t4u5v6",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "6D5H",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(d) Safety Considerations",
      "questionBody": "Have inhibitors been identified that did not have significant findings in a non-rodent toxicology study?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "g1h2i3j4-k5l6-m7n8-o9p0-q1r2s3t4u5v6", 
          "answer": "YES",
          "description": "",
          "isInverted": null,
          "weight": 1,
          "id": "w6v5u4t3-s2r1-q0p9-o8n7-m6l5k4j3i2h1",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "g1h2i3j4-k5l6-m7n8-o9p0-q1r2s3t4u5v6",
          "answer": "NO",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "b1c2d3e4-f5g6-h7i8-j9k0-l1m2n3o4p5q6",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "g1h2i3j4-k5l6-m7n8-o9p0-q1r2s3t4u5v6",
          "answer": "UNKNOWN",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "r6q5p4o3-n2m1-l0k9-j8i7-h6g5f4e3d2c1",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "g1h2i3j4-k5l6-m7n8-o9p0-q1r2s3t4u5v6",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "6D5I",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(d) Safety Considerations",
      "questionBody": "Have inhibitors been identified that did not have significant findings in a phase 1 clinical trial?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "g1h2i3j4-k5l6-m7n8-o9p0-q1r2s3t4u5v6",
          "answer": "YES",
          "description": "",
          "isInverted": null,
          "weight": 1,
          "id": "w6v5u4t3-s2r1-q0p9-o8n7-m6l5k4j3i2h1",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "g1h2i3j4-k5l6-m7n8-o9p0-q1r2s3t4u5v6",
          "answer": "NO",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "b1c2d3e4-f5g6-h7i8-j9k0-l1m2n3o4p5q6",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "g1h2i3j4-k5l6-m7n8-o9p0-q1r2s3t4u5v6",
          "answer": "UNKNOWN",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "r6q5p4o3-n2m1-l0k9-j8i7-h6g5f4e3d2c1",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "g1h2i3j4-k5l6-m7n8-o9p0-q1r2s3t4u5v6",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "6D5J",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(d) Safety Considerations",
      "questionBody": "Have inhibitors been identified that did not have significant findings in a phase 2 clinical trial?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "g1h2i3j4-k5l6-m7n8-o9p0-q1r2s3t4u5v6",
          "answer": "YES",
          "description": "",
          "isInverted": null,
          "weight": 1,
          "id": "w6v5u4t3-s2r1-q0p9-o8n7-m6l5k4j3i2h1",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "g1h2i3j4-k5l6-m7n8-o9p0-q1r2s3t4u5v6",
          "answer": "NO",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "b1c2d3e4-f5g6-h7i8-j9k0-l1m2n3o4p5q6",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "g1h2i3j4-k5l6-m7n8-o9p0-q1r2s3t4u5v6",
          "answer": "UNKNOWN",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "r6q5p4o3-n2m1-l0k9-j8i7-h6g5f4e3d2c1",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "g1h2i3j4-k5l6-m7n8-o9p0-q1r2s3t4u5v6",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "6D5K",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(d) Safety Considerations",
      "questionBody": "Have inhibitors been identified that did not have significant findings in a phase 3 clinical trial?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "g1h2i3j4-k5l6-m7n8-o9p0-q1r2s3t4u5v6",
          "answer": "YES",
          "description": "",
          "isInverted": null,
          "weight": 1,
          "id": "w6v5u4t3-s2r1-q0p9-o8n7-m6l5k4j3i2h1",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "g1h2i3j4-k5l6-m7n8-o9p0-q1r2s3t4u5v6",
          "answer": "NO",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "b1c2d3e4-f5g6-h7i8-j9k0-l1m2n3o4p5q6",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "g1h2i3j4-k5l6-m7n8-o9p0-q1r2s3t4u5v6",
          "answer": "UNKNOWN",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "r6q5p4o3-n2m1-l0k9-j8i7-h6g5f4e3d2c1",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "g1h2i3j4-k5l6-m7n8-o9p0-q1r2s3t4u5v6",
      "isArchived": false,
      "isDeleted": false
    },
    {
      "identification": "6D5L",
      "module": "TargetPromotionQuestions",
      "section": "Section 6: Likelihood of identifying and inhibitor/activator",
      "subSection": "(d) Safety Considerations",
      "questionBody": "Are drugs that inhibit this target known that do not have serious warnings or contraindications in their prescribing information?",
      "questionType": "MultipleChoice",
      "isRequired": false,
      "isInverted": false,
      "isDisabled": false,
      "weight": 0,
      "isAdminOnly": false,
      "possibleAnswers": [
        {
          "questionId": "g1h2i3j4-k5l6-m7n8-o9p0-q1r2s3t4u5v6",
          "answer": "YES",
          "description": "",
          "isInverted": null,
          "weight": 1,
          "id": "w6v5u4t3-s2r1-q0p9-o8n7-m6l5k4j3i2h1",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "g1h2i3j4-k5l6-m7n8-o9p0-q1r2s3t4u5v6",
          "answer": "NO",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "b1c2d3e4-f5g6-h7i8-j9k0-l1m2n3o4p5q6",
          "isArchived": false,
          "isDeleted": false
        },
        {
          "questionId": "g1h2i3j4-k5l6-m7n8-o9p0-q1r2s3t4u5v6",
          "answer": "UNKNOWN",
          "description": "",
          "isInverted": null,
          "weight": 0,
          "id": "r6q5p4o3-n2m1-l0k9-j8i7-h6g5f4e3d2c1",
          "isArchived": false,
          "isDeleted": false
        }
      ],
      "id": "g1h2i3j4-k5l6-m7n8-o9p0-q1r2s3t4u5v6",
      "isArchived": false,
      "isDeleted": false
    }
  ]
}